Volume 35 Issue 2
Mar.  2019
Turn off MathJax
Article Contents
Article Navigation >  Journal of Nanjing University of traditional Chinese Medicine  > 2019  >  35(2): 139-143
YI Ting, ZHENG Ting-ting, LIU Jing-han, YAN Tong. Effects of TCM Syndrome Differentiation Combined with Adefovir Dimethoate on Liver Function， Liver Fibrosis and Inflammatory Reaction in Patients with Chronic Hepatitis B[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(2): 139-143.
Citation: YI Ting, ZHENG Ting-ting, LIU Jing-han, YAN Tong. Effects of TCM Syndrome Differentiation Combined with Adefovir Dimethoate on Liver Function， Liver Fibrosis and Inflammatory Reaction in Patients with Chronic Hepatitis B[J]. Journal of Nanjing University of traditional Chinese Medicine, 2019, 35(2): 139-143.
shu

Effects of TCM Syndrome Differentiation Combined with Adefovir Dimethoate on Liver Function， Liver Fibrosis and Inflammatory Reaction in Patients with Chronic Hepatitis B

  • Publish Date: 2019-03-10
    Abstract
  • OBJECTIVE To investigate the effects of TCM syndrome differentiation combined with adefovir dimethoate on liver function， liver fibrosis and inflammatory reaction in patients with chronic hepatitis B (CHB). METHODS 164 patients with chronic hepatitis B in our hospital from December 2010 to December 2017 were divided into two groups， 82 patients in each group. The control group were treated with adefovir dimethoate orally， while the treatment group were treated with TCM syndrome differentiation on the basis of oral adefovir dipivoxil， the course of treatment for 3 months. The changes of liver function， liver fibrosis and inflammatory reaction of two groups were compared. RESULTS The obvious efficiency， effective rate and reduction of TCM syndrome score after treatment of the treatment group were significantly improved compared with those before treatment (P<0.05，P<0.01). The improvement of liver function in treatment group was significantly better than that of the control group and significantly improved than that before treatment(P<0.01). HBV-DNA negative conversion rate was significantly higher than that of the control group and significantly improved than that before treatment (P<0.05). Hyaluronic acid (HA)， type Ⅳ collagen (Ⅳ-C) and laminin (LN) were significantly lower in the treatment group than in the control group and significantly improved than that before treatment (P<0.01). The content of transforming growth factor(TGF-β1)， the hypersensitive C-reactive protein (hs-CRP)， tumor necrosis factor-α (TNF-α) were significantly decreased than that of the control group， and are obviously improved before the treatment. There was statistical significance(P<0.01). CONCLUSION The combination of the syndrome differentiation and adefovir dipivoxil in the treatment of chronic hepatitis B can significantly improve the liver function， liver fibrosis and inflammation of the body.

     

    • FullText(HTML)
  • loading
    • References(20)
  • [1]
    GISH RG， GIVEN BD， LAI CL， et al. Chronic hepatitis B: Virology， natural history， current management and a glimpse at future opportunities[J]. Antiviral Res， 2015， 121(3):47-58.
    [2]
    BURNS GS， THOMPSON AJ. Viral hepatitis B: Clinical and epidemiological characteristics[J]. Cold Spring Harb Perspect Med， 2014， 4(12):24-35.
    [3]
    赵建美，费玉玲，邵岩. 中药红曲对高脂血症伴肝功能异常患者血脂和肝功能的影响[J].医学理论与实践，2018，31(21): 3226-3228.
    [4]
    杨旻昕，洪庆祥，岑怡. 复方清降保龄液联合多烯磷脂酰胆碱胶囊治疗非酒精性脂肪肝病的临床疗效及对患者血脂、肝功能和肝纤维化指标的影响[J]. 中国中西医结合消化杂志，2018，26(10): 829-833.
    [5]
    郑明武，邹鲁，陈玉如. 中药联合甘利欣、优思弗治疗自身免疫性肝炎的效果观察[J].中国中医药科技，2018，25(5):763-765.
    [6]
    王贵强，王福生，成军，等. 慢性乙型肝炎防治指南(2015年版)[J]. 中华实验和临床感染病杂志（电子版），2015，19(5):1-18.
    [7]
    中药新药临床研究指导原则(试行)[M]. 北京:中国医药科技出版社，2002: 147-150，233-237.
    [8]
    CHEN J，WANG L， FU Y， et al. The co-inhibitory pathway and cellular immune imbalance in the progress of HBV infection[J]. Hepatol Int， 2014， 8(1):55-63.
    [9]
    LIU YM， XU QY， CHEN JX， et al. Investigation on effects of the nourishing kidney and eliminating toxicity decoction on immunological imbalance of Th1， Th17 and Treg in HBV transgenic mice[J]. Int J Clin Exp Med， 2014， 8(5):6735-6742.
    [10]
    赵卫华，王燕红，丛敏. TGF-β1/Smads信号通路在肝脏纤维化中的作用研究进展[J]. 肝脏，2016，21(10):877-879.
    [11]
    张素艳，张静，耿晓妍. 慢性乙型肝炎合并高脂血症患者应用阿托伐他汀后血清CRP、TNF-α、IL-6及IL-10的变化[J]. 胃肠病学和肝病学杂志，2014，23(10):1195-1197.
    [12]
    LIEDTKE C， TRAUTWEIN C. The role of TNF and Fas dependent signaling in animal models of inflammatory liver injury and liver cancer[J]. Eur J Cell Biol， 2012， 91(6):582-589.
    [13]
    VLACHOGIANNAKOS J， PAPATHEODORIDIS G. Hepatocellular carcinoma in chronic hepatitis B patients under antiviral therapy[J]. World J Gastroenterol， 2013， 19(47):8822-8830.
    [14]
    FUNG J， LAI CL， YUEN MF. Management of chronic hepatitis B in severe liver disease[J]. World J Gastroenterol， 2014， 20(43):16053-16061.
    [15]
    张亚蕾，郑天慧，刘伟. 扶正化瘀方对原代大鼠肝细胞中CYP450的影响[J].中国实验方剂学杂志，2018，24(9)：22-28.
    [16]
    刘银，王瑶，苏笮斌. 中药复方养生茶对酒精性肝损伤大鼠的保护作用及其机制研究[J].慢性病学杂志，2018，19(2)：135-138.
    [17]
    朱慧，平键，徐列明. NF-κB通路在肝纤维化进展和中药抗肝纤维化机制中的作用[J].临床肝胆病杂志，2018，34(4)：17-23.
    [18]
    田景振，杨振宁. 中医药抗病毒研究思路、理论创新与基本路径[J].山东中医杂志，2018，12(6):439-444.
    [19]
    赵薪苑，陈婧，方建国. 中药和天然药物中黄酮抗病毒活性及其机制研究进展[J].医药导报，2018，37(4):410-415.
    [20]
    李爱芝. 一贯煎联合阿德福韦酯治疗慢性乙型肝炎早期肝硬化25 例[J].中医研究，2012，3（25）：245-247.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索
    Get Citation
    PDF
    XML

    Article Metrics

    Article views (665) PDF downloads(494) Cited by()
    Proportional views
    Related

    Copyright © Journal of Nanjing University of traditional Chinese Medicine

    Sponsored by：Nanjing University of traditional Chinese MedicineAddress：No.138 xianlin Avenue, Qixia District, Nanjing cityChina Pos：210023

    Tel：025-85811935Email：xb@njucm.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return